Clinical Trial Update: Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing daily dosing of levalbuterol, racemic albuterol, and placebo in pediatric subjects with asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Levalbuterol (Levalbuterol)
• Racemic albuterol (albuterol (racemic))

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED